Cleared Traditional

K021495 - QIVA

K021495 is an FDA 510(k) clearance for QIVA, manufactured by Pie Medical Imaging BV. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 145-day FDA review.

K021495 · Pie Medical Imaging BV · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2002
Decision
145d
Days
Class 2
Risk

K021495 is an FDA 510(k) clearance for the QIVA. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Pie Medical Imaging BV (Indianpolis, US). The FDA issued a Cleared decision on October 1, 2002 after a review of 145 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Pie Medical Imaging BV devices

FDA 510(k) Submission Details - K021495

510(k) Number K021495 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 09, 2002
Decision Date October 01, 2002
Days to Decision 145 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 125d · This submission: 145d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 360
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K021495.
NEWCOR
K020440 · Siemens Medical Systems, Inc. · Dec 2002
T-WAVE ALTERMANS (TWA) ALGORITHM OPTION
K023380 · General Electric Medical Systems Information Techn · Dec 2002
RADIANALYZER, MODEL 12710
K022188 · Radi Medical Systems AB · Oct 2002
QUINTON Q-CATH, MODEL 000460
K021906 · Quinton, Inc. · Sep 2002
MAC-LAB/CARDIOLAB EP/COMBOLAB
K021366 · General Electric Medical Systems Information Techn · Jul 2002
PHYSIOLOG, SERIES 95000
K013032 · Camtronics, Ltd. · Jun 2002